A phase II study of myeloablative allogeneic hematopoietic stem cell transplantation (aHSCT) for acute lymphoblastic leukemia (ALL) in older patients using fludarabine and total body irradiation (Flu/TBI).

Omer Jamy,Donna Salzman,Antonio Di Stasi,Racquel Innis-Shelton,Costa Luciano,Lawrence S. Lamb,Shin Mineishi,Ayman Saad

A phase II study of myeloablative allogeneic hematopoietic stem cell transplantation (aHSCT) for acute lymphoblastic leukemia (ALL) in older patients using fludarabine and total body irradiation (Flu/TBI).

2019

Omer Jamy
Donna Salzman
Antonio Di Stasi
Racquel Innis-Shelton
Costa Luciano
Lawrence S. Lamb
Shin Mineishi
Ayman Saad

TPS7069Background: Older adults with ALL have poor survival outcomes. Although aHSCT can be curative when used as consolidation after complete remission (CR), advanced age, limited performance stat...

Keywords:

Pathology
Total body irradiation
Hematopoietic stem cell transplantation
Lymphoblastic Leukemia
Oncology
Phases of clinical research
Medicine
Internal medicine
Fludarabine
older patients
complete remission

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations